712 related articles for article (PubMed ID: 26989193)
1. Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors.
Galán M; Varona S; Orriols M; Rodríguez JA; Aguiló S; Dilmé J; Camacho M; Martínez-González J; Rodriguez C
Dis Model Mech; 2016 May; 9(5):541-52. PubMed ID: 26989193
[TBL] [Abstract][Full Text] [Related]
2. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.
Vinh A; Gaspari TA; Liu HB; Dousha LF; Widdop RE; Dear AE
J Vasc Res; 2008; 45(2):143-52. PubMed ID: 17957103
[TBL] [Abstract][Full Text] [Related]
3. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.
Krishna SM; Seto SW; Jose R; Li J; Moxon J; Clancy P; Crossman DJ; Norman P; Emeto TI; Golledge J
Clin Sci (Lond); 2017 Jun; 131(12):1261-1281. PubMed ID: 28364044
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
Qin Y; Cao X; Guo J; Zhang Y; Pan L; Zhang H; Li H; Tang C; Du J; Shi GP
Cardiovasc Res; 2012 Dec; 96(3):401-10. PubMed ID: 22871592
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
Lu HY; Huang CY; Shih CM; Chang WH; Tsai CS; Lin FY; Shih CC
PLoS One; 2015; 10(4):e0121077. PubMed ID: 25876091
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics.
Orriols M; Varona S; Martí-Pàmies I; Galán M; Guadall A; Escudero JR; Martín-Ventura JL; Camacho M; Vila L; Martínez-González J; Rodríguez C
Cardiovasc Res; 2016 Jun; 110(3):431-42. PubMed ID: 27089918
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model.
Cheng J; Koenig SN; Kuivaniemi HS; Garg V; Hans CP
J Am Heart Assoc; 2014 Oct; 3(6):e001064. PubMed ID: 25349182
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.
Webb NR; De Beer MC; Wroblewski JM; Ji A; Bailey W; Shridas P; Charnigo RJ; Noffsinger VP; Witta J; Howatt DA; Balakrishnan A; Rateri DL; Daugherty A; De Beer FC
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1156-65. PubMed ID: 25745063
[TBL] [Abstract][Full Text] [Related]
12. Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice.
Inoue N; Muramatsu M; Jin D; Takai S; Hayashi T; Katayama H; Kitaura Y; Tamai H; Miyazaki M
Atherosclerosis; 2009 Jun; 204(2):359-64. PubMed ID: 18996524
[TBL] [Abstract][Full Text] [Related]
13. Cortistatin attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the ERK1/2 signaling pathways.
Chai H; Tao Z; Chen W; Xu Y; Huang F; Su C; Chen X
Biochem Biophys Res Commun; 2018 Jan; 495(2):1801-1806. PubMed ID: 29225168
[TBL] [Abstract][Full Text] [Related]
14. The Paraoxonase Gene Cluster Protects Against Abdominal Aortic Aneurysm Formation.
Yan YF; Pei JF; Zhang Y; Zhang R; Wang F; Gao P; Zhang ZQ; Wang TT; She ZG; Chen HZ; Liu DP
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):291-300. PubMed ID: 27908891
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse.
Moran CS; Rush CM; Dougan T; Jose RJ; Biros E; Norman PE; Gera L; Golledge J
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):898-907. PubMed ID: 26966276
[TBL] [Abstract][Full Text] [Related]
16. AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
Ma H; Wang YL; Hei NH; Li JL; Cao XR; Dong B; Yan WJ
J Mol Med (Berl); 2020 Apr; 98(4):541-551. PubMed ID: 32060588
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term chloroquine administration on the natural history of aortic aneurysms in mice.
Ramadan A; Wheatcroft MD; Quan A; Singh KK; Lovren F; Dhingra N; Teoh H; Al-Omran M; Leong-Poi H; Verma S
Can J Physiol Pharmacol; 2015 Aug; 93(8):641-8. PubMed ID: 26099030
[TBL] [Abstract][Full Text] [Related]
18. PM2.5 promotes abdominal aortic aneurysm formation in angiotensin Ⅱ-infused apoe-/- mice.
Jun X; Jin G; Fu C; Jinxuan Z; Xueling L; Jiaxin H; Shuaihua Q; Anqi S; Jianzhou C; Lian Z; Xiwen Z; Baoli Z; Biao X
Biomed Pharmacother; 2018 Aug; 104():550-557. PubMed ID: 29800919
[TBL] [Abstract][Full Text] [Related]
19. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
[TBL] [Abstract][Full Text] [Related]
20. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
